PET and PET/CT Imaging of Neuroendocrine Tumors Richard P. Baum Vikas Prasad Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms that are characterized by their endocrine metabolism and histology…
Carcinoma of Unknown Primary: Including Paraneoplastic Neurological Syndromes Jennifer Rodriguez-Ferrer Richard L. Wahl Carcinoma of unknown primary (CUP) accounts for 3% to 5% of all new cancer diagnoses. It is…
Gastrointestinal Stromal Tumors Annick D. Van den Abbeele Ertuk Mehmet Richard J. Tetrault In 1983, Mazur and Clark (1) described gastrointestinal stromal tumors (GISTs) as a distinctive subgroup of gastrointestinal…
Genitourinary Malignancies Heiko Schöder General Considerations Urologic malignancies account for approximately 25% of all new cancers in the United States (1). The clinical utility of positron emission tomography (PET) with…
PET and PET/CT in Ovarian Cancer Hedieh Eslamy Robert Bristow Richard L. Wahl Ovarian cancer accounts for about 3% of all cancers among women and ranks second in frequency among…
Cervical and Uterine Cancer Perry W. Grigsby The initial diagnosis and staging of most gynecologic malignancies are commonly achieved by history and physical examination and by use of selected imaging…
Pancreatic and Hepatobiliary Cancers Oleg Teytelboym Dominique Delbeke Richard L. Wahl Pancreatic Carcinoma Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, accounting for 5% of cancer related…
Applications for Fluorodeoxyglucose PET and PET/CT in the Evaluation of Patients with Colorectal Carcinoma Dominique Delbeke Colorectal cancer is the third most common cause of cancer in men and women,…
PET in Breast Cancers Farrokh Dehdashti Breast cancer is the most common malignancy in women, accounting for approximately 26% of all female cancers. It is estimated that in the year…
